Sameek Roychowdhury, Ph.D.
Affiliations: | 2004 | Ohio State University, Columbus, Columbus, OH |
Area:
Oncology, Immunology, PathologyGoogle:
"Sameek Roychowdhury"Parents
Sign in to add mentor| Michael A. Caligiuri | grad student | 2004 | Ohio State | |
| (Interleukin -15: Biology, pathophysiology, and pre-clinical application in disease.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Chen HZ, Bonneville R, Paruchuri A, et al. (2021) Genomic and Transcriptomic Characterization of Relapsed SCLC Through Rapid Research Autopsy. Jto Clinical and Research Reports. 2: 100164 |
| Paruchuri A, Chen HZ, Bonneville R, et al. (2020) Research Autopsy Demonstrates Polyclonal Acquired Resistance in a Patient With Metastatic GI Stromal Tumor. Jco Precision Oncology. 4 |
| Makawita S, K Abou-Alfa G, Roychowdhury S, et al. (2020) Infigratinib in patients with advanced cholangiocarcinoma with gene fusions/translocations: the PROOF 301 trial. Future Oncology (London, England) |
| Wu C, Williams TM, Robb R, et al. (2020) Phase I Trial of Trametinib with Neoadjuvant Chemoradiation in Patients with Locally Advanced Rectal Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Brock P, Bustamante Alvarez J, Mortazavi A, et al. (2020) Co-occurrence of multiple endocrine neoplasia type 4 and spinal neurofibromatosis: a case report. Familial Cancer |
| Krook MA, Lenyo A, Wilberding M, et al. (2020) Efficacy of FGFR inhibitors and combination therapies for acquired resistance in FGFR2-fusion cholangiocarcinoma. Molecular Cancer Therapeutics |
| Bonneville R, Krook MA, Chen HZ, et al. (2020) Detection of Microsatellite Instability Biomarkers via Next-Generation Sequencing. Methods in Molecular Biology (Clifton, N.J.). 2055: 119-132 |
| Noonan AM, Lustberg MB, Schnell P, et al. (2020) A phase Ib adaptive study of dasatinib for the prevention of oxaliplatin-induced neuropathy in patients with metastatic colorectal cancer receiving FOLFOX chemotherapy and bevacizumab. Journal of Clinical Oncology. 38 |
| Krook MA, Silverman IM, Murugesan K, et al. (2020) Pan-cancer analysis of FGFR1-3 genomic alterations to reveal a complex molecular landscape. Journal of Clinical Oncology. 38: 3620-3620 |
| Drake CG, Johnson ML, Spira AI, et al. (2020) Personalized viral-based prime/boost immunotherapy targeting patient-specific or shared neoantigens: Immunogenicity, safety, and efficacy results from two ongoing phase I studies. Journal of Clinical Oncology. 38: 3137-3137 |